Literature DB >> 21397214

Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.

Puwang Li1, Yichao Wang, Fanbo Zeng, Lijue Chen, Zheng Peng, Ling Xue Kong.   

Abstract

Folate-chitosan (FA-CS) conjugates synthesized by coupling FA with CS render new and improved functions because the original properties of CS are maintained and the targeting ligand of FA is incorporated. In this work, FA-CS conjugates were synthesized based on chemical linking of carboxylic group of FA with amino group of CS as confirmed by Fourier transform spectroscopy (FTIR) and nuclear magnetic resonance ((1)H NMR). FA-CS conjugates displayed less crystal nature when compared to CS. The FA-CS nanoparticles (NPs) were prepared by crosslinking FA-CS conjugates with sodium tripolyphosphate (STPP). Positively charged FA-CS nanoparticles were spherical in shape with a particle size of about 100 nm. Cellular uptake of CS or FA-CS nanoparticles was assayed by fluorescent microscopy using calcein as fluorescent marker in colon cancer cells (HT-29). The FA-CS nanoparticles exhibited improved uptake of HT-29 and could become a potential targeted drug delivery system for colorectal cancer.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397214     DOI: 10.1016/j.carres.2011.01.027

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  20 in total

1.  Core-shell drug carrier from folate conjugated chitosan obtained from prawn shell for targeted doxorubicin delivery.

Authors:  Md Sazedul Islam; Papia Haque; Taslim U Rashid; M Nuruzzaman Khan; Abul K Mallik; M Nazrul I Khan; Mala Khan; Mohammed Mizanur Rahman
Journal:  J Mater Sci Mater Med       Date:  2017-02-16       Impact factor: 3.896

Review 2.  Basics to advances in nanotherapy of colorectal cancer.

Authors:  Ankita Tiwari; Shivani Saraf; Ankit Jain; Pritish K Panda; Amit Verma; Sanjay K Jain
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

3.  Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.

Authors:  Yichao Wang; Puwang Li; Lingxue Kong
Journal:  AAPS PharmSciTech       Date:  2013-03-06       Impact factor: 3.246

4.  Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.

Authors:  Raúl Ortiz; Laura Cabeza; José L Arias; Consolación Melguizo; Pablo J Álvarez; Celia Vélez; Beatriz Clares; Antonia Áranega; Jose Prados
Journal:  AAPS J       Date:  2015-04-17       Impact factor: 4.009

5.  Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.

Authors:  Zhonggen Shi; Rui Guo; Weichang Li; Yi Zhang; Wei Xue; Yu Tang; Yuanming Zhang
Journal:  J Mater Sci Mater Med       Date:  2013-12-11       Impact factor: 3.896

Review 6.  Targeted nanoparticles for colorectal cancer.

Authors:  Bruno A Cisterna; Nazila Kamaly; Won Il Choi; Ali Tavakkoli; Omid C Farokhzad; Cristian Vilos
Journal:  Nanomedicine (Lond)       Date:  2016-08-16       Impact factor: 5.307

7.  Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.

Authors:  Ran Tao; Chengzhang Wang; Yin Lu; Changwei Zhang; Hao Zhou; Hongxia Chen; WenJun Li
Journal:  Int J Nanomedicine       Date:  2020-04-22

8.  Synthesis of folate‑chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells.

Authors:  Lichun Cheng; Hui Ma; Mingkun Shao; Qing Fan; Huiyi Lv; Jinyong Peng; Tangna Hao; Daiwei Li; Chenyang Zhao; Xingyue Zong
Journal:  Mol Med Rep       Date:  2017-06-09       Impact factor: 2.952

Review 9.  Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer.

Authors:  Kangkang Ying; Bingjun Bai; Xing Gao; Yuzi Xu; Hangxiang Wang; Binbin Xie
Journal:  Front Bioeng Biotechnol       Date:  2021-07-07

10.  Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting.

Authors:  J P Tiernan; S L Perry; E T Verghese; N P West; S Yeluri; D G Jayne; T A Hughes
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.